Barbara Fazeny

Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel - a phase II study

Barbara Fazeny, Udo Zifko, Siegfried Meryn et al. · Cancer Chemotherapy and Pharmacology · 1996 · 67 citations

Advanced Breast Cancer, Medicine, Pharmacology +7

Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription

Hanna Harant, Irina Korschineck, Georg Krupitza et al. · British Journal of Cancer · 1993 · 33 citations · Full text

Polymerase Chain Reaction, Signal Transduction, Oncogenic Agent +9

Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin’s lymphoma (NHL). A multi- center trial by the Austrian Working Group For Medical Tumor Therapy

Michael Fridrik, Richard Greil, H. Hausmaninger et al. · Annals of Hematology · 1997 · 27 citations

Lymphoid Neoplasia, Medicine, Multi- Center Trial +9

Does 99mTc-Sestamibi in High-Grade Malignant Brain Tumors Reflect Blood–Brain Barrier Damage Only?

Anton Staudenherz, Barbara Fazeny, Christine Marosi et al. · NeuroImage · 2000 · 20 citations

Neuro-oncology, Medicine, Malignant Blood Disorder +6

Amonafide as first-line chemotherapy for metastatic breast cancer

Gabriela Kornek, Markus Raderer, D. Depisch et al. · European Journal of Cancer · 1994 · 20 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +4